Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
about
Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury.A role for thrombin in liver fibrosis.Antithrombotic activities of aqueous extract from Gardenia jasminoides and its main constituent.SSR182289A enhances thrombolysis induced by fibrinolytic agents in rabbit models of venous and arterial thrombosis.The antithrombotic effect of borneol related to its anticoagulant property.
P2860
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
@en
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
@nl
type
label
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
@en
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
@nl
prefLabel
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
@en
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor.
@nl
P2093
P356
P1476
Antithrombotic properties of SSR182289A, a new, orally active thrombin inhibitor
@en
P2093
Herbert JM
Lechaire I
O'Connor SE
Sainte-Marie M
P304
P356
10.1124/JPET.102.044610
P407
P577
2003-02-01T00:00:00Z